CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Design of the Effect of EMPaglifozin on ExeRcise ability and HF-symptoms, In patients with chronic heArt faiLure (EMPERIAL) trials of empagliflozin in patients with chronic heart failure with reduced or preserved ejection fraction
DOI 10.1055/s-0039-1688299
Bibliografische Angaben
Nachweis in CareLit
Autor:innenW Abraham, S Anker, A Salsali, B Peil, C Zeller, M Brun, H Macesic, M Brueckmann, JA Lindenfeld, P Ponikowski
ZeitschriftDiabetologie und Stoffwechsel
AusgabeS 01 S 01/2019
Jahrgang / SeitenJg. 14
Kernaussage aus der Literatur
Abstract-Vorschau
Design of the Effect of EMPaglifozin on ExeRcise ability and HF-symptoms, In patients with chronic heArt faiLure (EMPERIAL) trials of empagliflozin in patients with chronic heart failure with reduced or preserved ejection fraction
Zitieren
Zitierempfehlung
W Abraham, S Anker, A Salsali, B Peil, C Zeller, M Brun, H Macesic, M Brueckmann, JA Lindenfeld, P Ponikowski (2019) Design of the Effect of EMPaglifozin on ExeRcise ability and HF-symptoms, In patients with chronic heArt faiLure (EMPERIAL) trials of empagliflozin in patients with chronic heart failure with reduced or preserved ejection fraction. Diabetologie und Stoffwechsel, 14 (S 01 S 01). https://doi.org/10.1055/s-0039-1688299
Mit CareLit weiterarbeiten